Bruker Co. (NASDAQ:BRKR) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Bruker Co. (NASDAQ:BRKR) have received an average rating of “Moderate Buy” from the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $80.82.

A number of research analysts have recently commented on the stock. Citigroup dropped their price objective on shares of Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. The Goldman Sachs Group dropped their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a research note on Tuesday, July 9th. TD Cowen dropped their price objective on shares of Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research note on Wednesday, August 7th. Wolfe Research downgraded shares of Bruker from an “outperform” rating to a “peer perform” rating in a research note on Monday, September 30th. Finally, Barclays assumed coverage on shares of Bruker in a research note on Tuesday. They set an “overweight” rating and a $75.00 price objective for the company.

Hedge Funds Weigh In On Bruker

Several institutional investors and hedge funds have recently made changes to their positions in the business. Lifestyle Asset Management Inc. raised its position in shares of Bruker by 1.3% during the 1st quarter. Lifestyle Asset Management Inc. now owns 12,534 shares of the medical research company’s stock valued at $1,177,000 after acquiring an additional 158 shares in the last quarter. Nisa Investment Advisors LLC raised its position in shares of Bruker by 20.0% during the 2nd quarter. Nisa Investment Advisors LLC now owns 991 shares of the medical research company’s stock valued at $63,000 after acquiring an additional 165 shares in the last quarter. Securian Asset Management Inc. increased its position in Bruker by 2.3% in the second quarter. Securian Asset Management Inc. now owns 7,766 shares of the medical research company’s stock worth $496,000 after buying an additional 175 shares during the period. Park Place Capital Corp increased its position in Bruker by 19.4% in the first quarter. Park Place Capital Corp now owns 1,139 shares of the medical research company’s stock worth $107,000 after buying an additional 185 shares during the period. Finally, Covestor Ltd increased its position in Bruker by 139.1% in the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock worth $34,000 after buying an additional 210 shares during the period. 79.52% of the stock is currently owned by hedge funds and other institutional investors.

Bruker Trading Up 3.2 %

Shares of BRKR stock opened at $62.45 on Monday. The firm has a 50-day moving average price of $65.10 and a 200 day moving average price of $69.16. Bruker has a twelve month low of $53.79 and a twelve month high of $94.86. The company has a market capitalization of $9.08 billion, a price-to-earnings ratio of 22.71, a PEG ratio of 2.52 and a beta of 1.18. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18.

Bruker (NASDAQ:BRKR) last announced its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting the consensus estimate of $0.52. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The firm had revenue of $800.70 million during the quarter, compared to the consensus estimate of $799.44 million. During the same quarter in the previous year, the company posted $0.50 EPS. The firm’s revenue for the quarter was up 17.4% on a year-over-year basis. Research analysts forecast that Bruker will post 2.61 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, September 16th. Stockholders of record on Monday, September 2nd were paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a dividend yield of 0.32%. The ex-dividend date was Friday, August 30th. Bruker’s dividend payout ratio (DPR) is currently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.